Unravelling the collateral damage of antibiotics on gut bacteria.

Animals Anti-Bacterial Agents / adverse effects Bacteria / classification Bacteria, Anaerobic / drug effects Bacteroides / drug effects Clostridioides difficile / drug effects Dicumarol / pharmacology Erythromycin / pharmacology Feces / microbiology Female Gastrointestinal Microbiome / drug effects Germ-Free Life Humans Macrolides / pharmacology Male Mice Microbiota / drug effects Symbiosis / drug effects Tetracyclines / pharmacology

Journal

Nature

ISSN: 1476-4687

Titre abrégé: Nature

Pays: England

ID NLM: 0410462

Informations de publication

Date de publication:
11 2021

Historique:

received: 06 11 2019

accepted: 01 09 2021

pubmed: 15 10 2021

medline: 15 1 2022

entrez: 14 10 2021

Statut: ppublish

Résumé

Antibiotics are used to fight pathogens but also target commensal bacteria, disturbing the composition of gut microbiota and causing dysbiosis and disease

Identifiants

DOI: 10.1038/s41586-021-03986-2 PMID: 34646011 PMC: PMC7612847

pubmed: 34646011

doi: 10.1038/s41586-021-03986-2

pii: 10.1038/s41586-021-03986-2

pmc: PMC7612847

mid: EMS145499

doi:

Substances chimiques

Anti-Bacterial Agents 0

Macrolides 0

Tetracyclines 0

Erythromycin 63937KV33D

Dicumarol 7QID3E7BG7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

120-124

Subventions

Organisme : European Research Council

ID : 819454

Pays : International

Organisme : Medical Research Council

ID : MC_UU_00025/11

Pays : United Kingdom

Informations de copyright

Références

Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544–545 (2016).

pubmed: 27126037 pmcid: 4939477 doi: 10.1126/science.aad9358

Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).

pubmed: 29555994 pmcid: 6108420 doi: 10.1038/nature25979

Cho, I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621–626 (2012).

pubmed: 22914093 pmcid: 3553221 doi: 10.1038/nature11400

Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705–721 (2014).

pubmed: 25126780 pmcid: 4134513 doi: 10.1016/j.cell.2014.05.052

Ruiz, V. E. et al. A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. Nat. Commun. 8, 518 (2017).

pubmed: 28894149 pmcid: 5593929 doi: 10.1038/s41467-017-00531-6

Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 7, 10410 (2016).

pubmed: 26811868 pmcid: 4737757 doi: 10.1038/ncomms10410

Parker, E. P. K. et al. Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India. Sci. Rep. 7, 9168 (2017).

pubmed: 28835659 pmcid: 5569098 doi: 10.1038/s41598-017-06862-0

Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).

pubmed: 27126039 doi: 10.1126/science.aad3503

Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).

pubmed: 29489753 doi: 10.1038/nature25973

Zimmermann, M., Patil, K. R., Typas, A. & Maier, L. Towards a mechanistic understanding of reciprocal drug–microbiome interactions. Mol. Syst. Biol. 17, e10116 (2021).

pubmed: 33734582 pmcid: 7970330 doi: 10.15252/msb.202010116

Vich Vila, A. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 11, 362 (2020).

pubmed: 31953381 pmcid: 6969170 doi: 10.1038/s41467-019-14177-z

Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 44, D1075–D1079 (2016).

pubmed: 26481350 doi: 10.1093/nar/gkv1075

Dethlefsen, L. & Relman, D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. USA 108, 4554–4561 (2011).

pubmed: 20847294 doi: 10.1073/pnas.1000087107

Uzan-Yulzari, A. et al. Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization. Nat. Commun. 12, 443 (2021).

pubmed: 33500411 pmcid: 7838415 doi: 10.1038/s41467-020-20495-4

Nagy, E., Boyanova, L., Justesen, U. S. & ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin. Microbiol. Infect. 24, 1139–1148 (2018).

pubmed: 29458156 doi: 10.1016/j.cmi.2018.02.008

European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. v.; http://www.eucast.org/clinical_breakpoints/ (2019).

Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).

pubmed: 29170280 pmcid: 5823247 doi: 10.1126/science.aal5240

Manfredo Vieira, S. et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359, 1156–1161 (2018).

pubmed: 29590047 doi: 10.1126/science.aar7201

Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945–D954 (2017).

pubmed: 27899562 doi: 10.1093/nar/gkw1074

Slimings, C. & Riley, T. V. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J. Antimicrob. Chemother. 69, 881–891 (2014).

pubmed: 24324224 doi: 10.1093/jac/dkt477

Baron, S., Diene, S. & Rolain, J.-M. Human microbiomes and antibiotic resistance. Hum. Microb. J. 10, 43–52 (2018).

doi: 10.1016/j.humic.2018.08.005

Tramontano, M. et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat. Microbiol. 3, 514–522 (2018).

pubmed: 29556107 doi: 10.1038/s41564-018-0123-9

Habib, G. et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J. 36, 3075–3128 (2015).

pubmed: 26320109 doi: 10.1093/eurheartj/ehv319

Kasper, D.L., F. A., Hauser S. L. & Longo D. L. Harrison’s Principles of Internal Medicine (McGraw-Hill, 2012).

Lobritz, M. A. et al. Antibiotic efficacy is linked to bacterial cellular respiration. Proc. Natl Acad. Sci. USA 112, 8173–8180 (2015).

pubmed: 26100898 pmcid: 4500273 doi: 10.1073/pnas.1509743112

French, G. L. Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin. J. Antimicrob. Chemother. 58, 1107–111 (2006).

pubmed: 17040922 doi: 10.1093/jac/dkl393

Jelic, D. & Antolovic, R. From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics (Basel) 5, 29 (2016).

pubmed: 27598215 doi: 10.3390/antibiotics5030029

Nemeth, J., Oesch, G. & Kuster, S. P. Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis. J. Antimicrob. Chemother. 70, 382–395 (2015).

pubmed: 25266070 doi: 10.1093/jac/dku379

Wald-Dickler, N., Holtom, P. & Spellberg, B. Busting the myth of “static vs cidal” a systemic literature review. Clin. Infect. Dis. 66, 1470–1474 (2018).

pubmed: 29293890 doi: 10.1093/cid/cix1127

Brochado, A. R. et al. Species-specific activity of antibacterial drug combinations. Nature 559, 259–263 (2018).

pubmed: 29973719 pmcid: 6219701 doi: 10.1038/s41586-018-0278-9

Brugiroux, S. et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat. Microbiol. 2, 16215 (2016).

pubmed: 27869789 doi: 10.1038/nmicrobiol.2016.215

Palleja, A. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 3, 1255–1265 (2018).

pubmed: 30349083 doi: 10.1038/s41564-018-0257-9

Schmidt, T. S. B., Raes, J. & Bork, P. The human gut microbiome: from association to modulation. Cell 172, 1198–1215 (2018).

pubmed: 29522742 doi: 10.1016/j.cell.2018.02.044

Milanese, A. et al. Microbial abundance, activity and population genomic profiling with mOTUs2. Nat. Commun. 10, 1014 (2019).

pubmed: 30833550 pmcid: 6399450 doi: 10.1038/s41467-019-08844-4

Feng, Q. et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 6, 6528 (2015).

pubmed: 25758642 doi: 10.1038/ncomms7528

Vogtmann, E. et al. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS ONE 11 (2016).

Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679–689 (2019).

pubmed: 30936547 pmcid: 7984229 doi: 10.1038/s41591-019-0406-6

Yu, J. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66, 70–78 (2017).

pubmed: 26408641 doi: 10.1136/gutjnl-2015-309800

Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).

pubmed: 25432777 pmcid: 4299606 doi: 10.15252/msb.20145645

Kultima, J. R. et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics 32, 2520–2523 (2016).

pubmed: 27153620 pmcid: 4978931 doi: 10.1093/bioinformatics/btw183

Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).

pubmed: 22930834 pmcid: 5554542 doi: 10.1038/nmeth.2089

Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).

pubmed: 22743772 doi: 10.1038/nmeth.2019

Frostegård, A. et al. Quantification of bias related to the extraction of DNA directly from soils. Appl. Environ. Microbiol. 65, 5409–5420 (1999).

pubmed: 10583997 pmcid: 91737 doi: 10.1128/AEM.65.12.5409-5420.1999

Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA 108, 4516–4522 (2011).

pubmed: 20534432 doi: 10.1073/pnas.1000080107

Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).

pubmed: 27214047 pmcid: 4927377 doi: 10.1038/nmeth.3869

Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).

pubmed: 2231712 doi: 10.1016/S0022-2836(05)80360-2

Matias Rodrigues, J. F., Schmidt, T. S. B., Tackmann, J. & von Mering, C. MAPseq: highly efficient k-mer search with confidence estimates, for rRNA sequence analysis. Bioinformatics 33, 3808–3810 (2017).

pubmed: 28961926 pmcid: 5860325 doi: 10.1093/bioinformatics/btx517

Nawrocki, E. P. & Eddy, S. R. Infernal 1.1: 100-fold faster RNA homology searches. Bioinformatics 29, 2933–2935 (2013).

pubmed: 24008419 pmcid: 3810854 doi: 10.1093/bioinformatics/btt509

Matias Rodrigues, J. F. & von Mering, C. HPC-CLUST: distributed hierarchical clustering for large sets of nucleotide sequences. Bioinformatics 30, 287–288 (2014).

pubmed: 24215029 doi: 10.1093/bioinformatics/btt657

Schmidt, T. S. B., Matias Rodrigues, J. F. & von Mering, C. Limits to robustness and reproducibility in the demarcation of operational taxonomic units. Environ. Microbiol. 17, 1689–1706 (2015).

pubmed: 25156547 doi: 10.1111/1462-2920.12610

Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8

McMurdie, P. J. & Holmes, S. Waste not, want not: why rarefying microbiome data is inadmissible. PLoS Comput. Biol. 10, e1003531 (2014).

pubmed: 24699258 pmcid: 3974642 doi: 10.1371/journal.pcbi.1003531

Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).

Chen, M. et al. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity. Toxicol. Sci. 122, 288–296 (2011).

pubmed: 21613233 doi: 10.1093/toxsci/kfr138

Cai, H. Y. et al. Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice. Acta Pharmacol. Sin. 34, 1397–1402 (2013).

pubmed: 24077632 pmcid: 4651057 doi: 10.1038/aps.2013.97

Herp, S. et al. Mucispirillum schaedleri antagonizes Salmonella virulence to protect mice against colitis. Cell Host Microbe 25, 681–694 (2019).

pubmed: 31006637 doi: 10.1016/j.chom.2019.03.004

Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462–467 (2019).

pubmed: 31158845 pmcid: 6597290 doi: 10.1038/s41586-019-1291-3

Sunagawa, S. et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. Methods 10, 1196–1199 (2013).

pubmed: 24141494 doi: 10.1038/nmeth.2693

Huerta-Cepas, J., Serra, F. & Bork, P. ETE 3: reconstruction, analysis, and visualization of phylogenomic data. Mol. Biol. Evol. 33, 1635–1638 (2016).

pubmed: 26921390 pmcid: 4868116 doi: 10.1093/molbev/msw046

Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).

pubmed: 21988835 pmcid: 3261699 doi: 10.1038/msb.2011.75

Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).

pubmed: 25371430 doi: 10.1093/molbev/msu300

Cani, P. D. & de Vos, W. M. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8, 1765 (2017).

pubmed: 29018410 pmcid: 5614963 doi: 10.3389/fmicb.2017.01765

Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).

pubmed: 29097494 doi: 10.1126/science.aan3706